Gensight Biologics SA
F:G49N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gensight Biologics SA
F:G49N
|
FR |
|
D
|
DNAPrint Genomics Inc
OTC:DNAG
|
US |
|
R
|
Resouro Gold Inc
OTC:RSGOF
|
CA |
|
K
|
K2 Gold Corp
OTC:KTGDF
|
CA |
|
LatAm Lithium Corp
OTC:PFFOD
|
CA |
|
W
|
Wellfield Technologies Inc
OTC:WFLDF
|
CA |
|
D
|
Dimension Computer Technology Co Ltd
TPEX:6140
|
TW |
|
B
|
BlockchainK2 Corp
F:KRL2
|
CA |
|
B
|
Brimstone Investment Corporation Ltd
JSE:BRN
|
ZA |
|
M
|
Matsa Resources Ltd
F:KB2
|
AU |
|
Peruvian Metals Corp
F:6D71
|
CA |
|
Positive Physicians Holdings Inc
OTC:PPHI
|
US |
|
First Resources Ltd
F:5F1
|
SG |
Bankruptcy Probability
Gensight Biologics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gensight Biologics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Gensight Biologics SA
PAR:SIGHT
|
25.2m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gensight Biologics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gensight Biologics SA has total debt of 9.2m EUR. This includes both short-term (0 EUR) and long-term (9.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
